Navigation Links
Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program
Date:10/14/2009

nd uncertainties that are inherent in the development of complex biologics and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2009 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx® are trademarks of Cardium Therapeutics, Inc.

Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM), Excellagen(TM), Excellarate(TM) and Osteorate(TM)

are trademarks of Tissue Repair Company.

Regranex® and other trademarks are the property of their respective owners.

SOURCE Cardium Therapeutics


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers
2. Scientific Journal Gene Therapy Reports That Cardiums Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
3. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
4. Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
5. Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
6. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
7. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
8. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
9. Cardium Provides Update Regarding Exchange Listing Compliance Plan Accepted by NYSE Amex
10. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
11. Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Randy Dotinga HealthDay Reporter ... parasite that causes malaria is growing increasingly resistant to the ... reports. But several new drugs are in development, and at ... against this global killer. "Although there has been considerable ... against malaria is far from won, and there is still ...
(Date:7/31/2014)... 31, 2014 ReputationChief.Com, a well-recognized ... online reputation management service named ‘Remove Pissed Consumer’. ... organizations get rid of Pissed Consumer Complaints. , ... extensive research. ReputationChief.Com management assigned the responsibility to ... who are struggling in their social or professional ...
(Date:7/31/2014)... July 31, 2014 -- A new study by researchers ... a peptide called caerulein can convert existing cells in ... diabetes-insulin-producing beta cells. The study, published online July 31 ... new approach to treating the estimated 3 million people ... with type 1 diabetes. , "We have found a ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... healthcare providers, strives in maintaining the highest standards ... That is why Healthpointe is offering Occupational ... surrounding employers, employees and patients. They also accept ... carriers. , Healthpointe’s Occupational Medicine services include, but ...
(Date:7/31/2014)... July 31, 2014 Dallas Fit Body ... Dallas, Texas to 3821 Ross Avenue, also in Dallas, in ... and potential members to burn fat and get in great ... move because he believes that the new space will help ... fitness results they want as well as accommodate new members ...
Breaking Medicine News(10 mins):Health News:Malaria Growing Resistant to Drugs Used to Fight It 2Health News:Malaria Growing Resistant to Drugs Used to Fight It 3Health News:ReputationChief.Com Announces a New Online Reputation Management Service 2Health News:A new way to generate insulin-producing cells in Type 1 diabetes 2Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2Health News:Dallas Fit Body Boot Camp Moves to New Location, Announces Grand Opening Set for Saturday August 9th 2
... Mom,s touch and diet Claire-Dominique Walker, PhD, ... The quality and quantity of maternal milk and maternal-infant ... according to recent research published in Developmental Psychobiology ... early in life can shape the physiology and behaviour ...
... N.C. A multidisciplinary team of University of North Carolina ... grant to develop computer models that will allow physicians to ... airway problems. The three co-principal investigators of the ... Stephanie Davis, MD, Chief of Pediatric Pulmonology in the School ...
... , THURSDAY, Feb. 3 (HealthDay News) -- ... and their doctors better understand the condition, a new ... a personal digital assistant (PDA) device. The patients used ... and other issues three times a day for 30 ...
... ANGELES (Feb. 2, 2011) A team of scientists from ... million grant from the California Institute for Regenerative Medicine ... discoveries for specific diseases. Additionally, another team ... million grant with a medical technology company aiming to develop ...
... HealthDay Reporter , WEDNESDAY, Feb. 2 (HealthDay News) -- ... increasingly common intestinal infection Clostridium difficile , which ... recurrence far better than currently used medications. Researchers ... drug often prescribed to C. difficile patients. ...
... By Maureen Salamon HealthDay Reporter , ... have devised a process to create ready-made, easily stored ... undergoing heart surgery or kidney dialysis. Using donor ... spent more than five years engineering the "off-the-shelf" blood ...
Cached Medicine News:Health News:Brains need love, too 2Health News:UNC researchers developing computer models for pediatric airway problems 2Health News:Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies 2Health News:Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies 3Health News:New Antibiotic Helps Prevent Recurrence of Dangerous Gut Infection 2Health News:New Antibiotic Helps Prevent Recurrence of Dangerous Gut Infection 3Health News:Researchers Craft Blood Vessels for Heart, Kidney Patients 2Health News:Researchers Craft Blood Vessels for Heart, Kidney Patients 3
(Date:7/31/2014)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... 2014, on Thursday, August 7, 2014 before markets open. ... and conference call at 8:00 a.m. Eastern time (5:00 ... the call and webcast to discuss financial results and ... by calling (800) 708-4540 (domestic) or (847) 619-6397 (international), ...
(Date:7/31/2014)... Cipla Europe NV ("Cipla") ... entered into a commercial collaboration, covering the territory ... countries, for BioQuiddity,s OneDose ReadyfusOR™ in regional anesthetic ... launch the CE Marked OneDose ReadyfusOR pre-filled with ... market late this year. The ready-to-use infusion systems ...
(Date:7/31/2014)... England , July 31, 2014 ... today announced that its subsidiary, Molecular Profiles Ltd., ... will support pharmaceutical and biotech drug developers during ... pharmaceutical development services will be supported by XenoGesis, ... to give clients a smarter route into formulation ...
Breaking Medicine Technology:Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management 2Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management 3Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3
... Reportlinker.com announces that a new market research report is available in its catalogue: ... Stakeholder Opinions: Vaccines in emerging markets (Latin ... , , ... Introduction , ...
... WEST WINDSOR, N.J. , July 7 ITelagen, ... announced that it was selected by Zweena, LLC of West ... record application. ITelagen, which was selected for its expertise in EHR ... this innovative solution. , , ...
Cached Medicine Technology:Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 2Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 3Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 5Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 6Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 7Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 8Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 9Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 10Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 11Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 12Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 13Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 14Zweena Selects ITelagen to Host Personal Health Records Application 2Zweena Selects ITelagen to Host Personal Health Records Application 3
... delicate urethral tissues. The gentle, ... provide nearly friction-free movement, without ... to maintain sterility. You simply ... own sterile water, avoiding contamination ...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
... Rochester Medical's line of ... intermittent catheters you would ... four product configurations - ... antibacterial hydro - are ...
Medicine Products: